The slip
PARKINSON RECEIPTno. 0018
16 Oct 2026, 14:53 UTColigodendrocytes, resilience
predictionDNAJC6 in oligodendrocytes differs in resilient donors (Lewy pathology, no parkinsonism)
registered1731c84c9aea4006
discovery+0.67 p=0.038 n=25
replication+0.18 p=0.477 n=30
neededp < 0.05 twice, same sign
did not replicate (discovery +0.67 p 0.038; held-out +0.18 p 0.477)
datasimulated substantia nigra cohort (84 donors)
DID NOT REPLICATE455b808d9554be855041f3fe…
follows d35ad60da23e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0018: DNAJC6 in oligodendrocytes, resilience
- power
- full sample +0.29 (p 0.147, n 55), 95% CI +0.02 to +0.51. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for age, sex and PMI: +0.31 (p 0.119, n 55). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis -0.52 (p 0.0075); controlling for it: +0.27 (p 0.165, n 55). could be the mix.
- skeptic
- leave-one-out range +0.21 to +0.38, sign flips 0; without severely affected donors +0.37 (p 0.066, n 46). robust.
- cell type
- no other cell group does better.
- axis
- braak beats resilience for DNAJC6 in oligodendrocytes: +0.46 (p 1.1e-5, n 84). proposing braak.
follow-up confirmed in ventral tegmental area.
follow-up DNAJC6 · oligodendrocytes · braak: ventral tegmental area +0.37 p 8.1e-4 (needs p < 0.017)